US2013079525A1PendingUtilityA1

Method for producing optically active 3-aminopiperidine or salt thereof

Assignee: KANEKA CORPPriority: Feb 19, 2007Filed: Nov 21, 2012Published: Mar 28, 2013
Est. expiryFeb 19, 2027(~0.6 yrs left)· nominal 20-yr term from priority
C07B 57/00C12P 41/006C12P 17/12C07D 211/56C07D 211/60
62
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a method for producing an optically active 3-aminopiperidine or salt thereof. In the method, a racemic nipecotamide is stereoselectively hydrolyzed to obtain an optically active nipecotamide and an optically active nipecotic acid in the presence of an enzyme source derived from an organism, and then the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by aroylation, Hofmann rearrangement, deprotection of the amino group and further deprotection; or the optically active nipecotamide is derived into an optically active aminopiperidine or salt thereof by selective protection with BOC, Hofmann rearrangement and further deprotection. It is possible by the present invention to produce an optically active 3-aminopiperidine or salt thereof useful as a pharmaceutical intermediate from an inexpensive and easily available starting material by easy method applicable to industrial manufacturing.

Claims

exact text as granted — not AI-modified
1 .- 18 . (canceled) 
     
     
         19 . An optically active 1-aroylnipecotamide derivative represented by the following formula (4): 
       
         
           
           
               
               
           
         
         wherein, * indicates an asymmetric carbon atom; Ar represents a phenyl group, a p-methylphenyl group or a p-chlorophenyl group. 
       
     
     
         20 . An optically active 1-aroyl-3-aminopiperidine derivative represented by the following formula (5): 
       
         
           
           
               
               
           
         
         wherein, * indicates an asymmetric carbon atom; Ar represents a phenyl group, a p-methylphenyl group or a p-chlorophenyl group. 
       
     
     
         21 . An optically active 1-aroyl-3-(protected amino)piperidine derivative represented by the following formula (6): 
       
         
           
           
               
               
           
         
         wherein, * indicates an asymmetric carbon atom; Ar represents a phenyl group, a p-methylphenyl group or a p-chlorophenyl group; R 2  represents a benzoyl group, a p-methylbenzoyl group, a p-chlorobenzoyl group or a tert-butoxycarbonyl group.

Join the waitlist — get patent alerts

Track US2013079525A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.